Page 43 - Journal of Structural Heart Disease Volume 5, Issue 6

267
Case Report
M, Cervera-Ceballos JJ, Amplatz K. Trans- venous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation. 1997;95:2162- 2168. DOI: 10.1161/01.CIR.95.8.2162
5. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between tran- scatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002;37:1707-1712.
6. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, et al. Early and late com- plications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol. 2002;39:1061-1065. DOI: 10.1016/S0735-1097(02)01711-4
7. Lee WC, Fang CY, Huang CF, Lin YJ, Wu CJ, Fang HY. Predictors of Atrial Septal De- fect Occluder Dislodgement. Int Heart J. 2015;56:428-431. DOI: 10.1536/ihj.15-065
8. Yamamoto T, Kanazawa H, Tanosaki S, Goto S, Kimura M, Tsuruta H, et al. A Nov- el Mechanism of Atrioventricular Block Following Transcatheter Closure of an Atrial Septal Defect. JACC Cardiovasc In- terv. 2016;9:2067-2069. DOI: 10.1016/j. jcin.2016.07.028
9. Geoffrey B, Crawford GB, Brindis RG, Kru- coff MW, Mansalis BP, Carroll JD. Percuta- neous atrial septal occluder devices and cardiac erosion: a review of the literature.
Catheter Cardiovasc Interv. 2012;80:157-
167. DOI: 10.1002/ccd.24347
10. Dickison, P, Harris V, Smith SD. Nickel hy-
persensitivity following closure of atrial septal defect: A case report and review of the literature. Australas J Dermatol. 2018;59:220-222. DOI: 10.1111/ajd.12787
11. Cooke JC, Gelman JS, Menahem S, Harper RW. Thrombus on ASD closure device: a call for caution. Heart, Lung and Circula- tion. 2000;9:30-31. DOI: 10.1046/j.1444- 2892.2000.009001030.x
12. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease. Circulation. 2016;134:e123-e155. DOI: 10.1161/CIR.0000000000000453
13. Pedra CAC, Pedra SF, Costa RN, Ribeiro MS, Nascimento W, Campanh LOS, et al. Mid- Term Outcomes after Percutaneous Clo- sure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device. J Inter- ven Cardiol. 2015;9999:1-8.
14. Anmar R, Hegazy R. Transcatheter Clo- sure of Secundum ASD Using Occlutech Figulla-N Device in Symptomatic Children Younger Than 2 Years of Age. J Invasive Cardiol. 2013;25:76-79
15.Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, et al. Inci- dence and Clinical Course of Thrombus Formation on Atrial Septal Defect and Patient Foramen Ovale Closure Devices
in 1,000 Consecutive Patients. J Am Coll Cardiol. 2004;43:302-309. DOI: 10.1016/j. jacc.2003.10.030
16. Nguyen AK, Palafox BA, Starr JP, Gates RN, Berdjis F. Endocarditis and Incomplete En- dothelialization 12 years After Amplatzer Septal Occluder Deployment. Tex Heart Inst J. 2016;43:227-231. DOI: 10.14503/ THIJ-14-4949
17. Yang D, Lu X, Hong Y, Xi T, Zhang D. The molecular mechanism for effects of TiN coating on NiTi alloy on endothelial cell function. Biomaterials. 2014;35:6195-6205. DOI: 10.1016/j.biomaterials.2014.04.069
18. Shen W, Cai K, Yang Z, Yan Y, Yang W, Liu P. Improved endothelialization of NiTi alloy by VEGF functionalized nanocoating. Col- loids Surf B Biointerfaces. 2012;94:347-353. DOI: 10.1016/j.colsurfb.2012.02.009
Teixeirense P. T. et al.
Thrombosis of an Occluder and Splenic Infarction
Cite this article as: Teixeirense PT, de Toledo JFB, Gubolino LA, Bragalha AA, Pereira CA. Very Late Thrombosis of an Atrial Septal Defect Occluder Device Causing a Massive Splenic Infarction. Structural Heart Disease. 2019;5(6):263- 267. DOI: https://doi.org/10.12945/j. jshd.2019.005.19